Factors affecting quantification in PET/CT imaging

Current Medical Imaging Reviews

Volumn 4, Issue 1, 2008, Pages 34-45

  Mawlawi, Osama ^a   Kappadath, S Cheenu ^a   Pan, Tinsu ^a   Rohren, Eric ^a   Macapinlac, Homer A ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONTRAST MEDIUM; FLUORODEOXYGLUCOSE F 18; GLUCOSE;

ANXIETY; ARTIFACT REDUCTION; BREATHING MECHANICS; CALIBRATION; CANCER STAGING; CLINICAL PROTOCOL; COMPUTED TOMOGRAPHY SCANNER; COMPUTER ASSISTED TOMOGRAPHY; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIET RESTRICTION; DRUG ACCUMULATION; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG UPTAKE; GLUCOSE BLOOD LEVEL; HUMAN; IMAGE ANALYSIS; IMAGE PROCESSING; IMAGE QUALITY; IMAGE RECONSTRUCTION; IMMOBILIZATION; LOW CARBOHYDRATE DIET; METAL IMPLANTATION; PATIENT COMPLIANCE; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; QUALITY CONTROL; QUANTITATIVE ANALYSIS; RELIABILITY; REVIEW; TREATMENT CONTRAINDICATION;

EID: 39049084957     PISSN: 15734056     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340508783502778     Document Type: Review

References (65)

1. Soret M, Bacharach SL, Buvat I. Partial Volume effect in tumor imaging. J Nucl Med 2007; 48: 932-945.
2. Hickeson M, Yun M, Matthies A, et al. use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET. Eur J Nucl Med Mot Imagin 2002; 29: 1639-1647.
3. Ramos CD, Erdi YE, Gonen M, et al. FDG-PET standardized uptake values in normal anatomical structures using iterative reconstruction segmented attenuation correction and filtered back-projection. Eur J Nucl Med 2001; 28(2): 155-64.
4. Etchebehere EC, Macapintac HA, Gonen M, et al. Qualitative and quantitative comparison between images obtained with filtered back projection and iterative reconstruction in prostate cancer lesions of (18)F-FDG PET. Q J Nucl Med 2002; 46(2): 122-30.
5. Riddell C, Carson RE, Carrasquillo JA, et al. Noise reduction in oncology FDG PET images by iterative reconstruction: a quantitative assessment. J Nucl Med 2001; 42(9): 1316-23.
6. Schöder H, Erdi YE, Chao K, Gonen M, Larson SM, Yeung HW. Clinical implications of different image reconstruction parameters for interpretation of whole-body PET studies in cancer patients. J Nucl Med 2004; 45(4): 559-66.
7. Visvikis D, Cheze-LeRest C, Costa DC, Bomanji J, Gacinovic S, Ell PJ. Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET. Eur J Nucl Med 2001; 28(9): 1326-35.
8. Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP. Influence of reconstruction iterations on 18F-FDG PET/CT standardized uptake values. J Nucl Med 2005; 46(3): 424-8.
9. Westerterp M, Pruim J, Oyen W, et al. Quantification of FDG PET studies using standardised uptake values in multi-centre trials: effects of image reconstruction, resolution and ROI definition parameters. Eur J Nucl Med Mol Imaging 2007; 34(3): 392-404.
10. Kappadath SC, Pan T, Erwin WD, Mawlawi O. Analysis of the Dependence of PET/CT Quantification on Iterative Reconstruction Parameters. IEEE MIC 2007 conference proceedings, Hawaii, USA.
11. Huang SC, Phelps ME, Hoffman EJ, Sideris K, Selin CJ, Kuhl DE. Noninvasive determination of local cerebral metabolic rate of glucose in man. Am J Physiol 1980; 238: E69-E82.
12. Phelps ME, Huang SC, Hoffman EJ, Selin CE Kuhl DE. Tomographic measurement of regional cerebral glucose metabolic rate in man with (F-18) fluorodeoxyglucose: Validation of method. Ann Neurol 1979; 6: 371-388.
13. Langen K-J, Braun U, Kops ER, et al. The influence of plasma glucose levels on fluorine-18-fluorodeoxyglucose uptake in bronchial carcinomas. J Nucl Med 1993; 34: 355-359.
14. Lindholm P, Minn H, Leskinen-Kallio S, et al. Influence if the blood glucose concentration on FDG uptake in cancer- a PET study. J Nucl Med 1993; 34: 1-6.
15. Hamburg LM, Hunter GT, Alpert NM, et al. The dose uptake ratio as an index of glucose metabolism: useful parameter or over simplification? J Nucl Med 1994; 35: 1308-1312.
16. 18F-FDG PET Imaging Detects Breast Cancer with High Sensitivity and Correlates Well with Histologic Subtypes. J Nucl Med 2006; 47: 1440-1446.
17. 18F-FDG-PET imaging in the detection of hepatocellular carcinoma. Nucl Med Commun 2005; 26: 315-321.
18. Boemer AR, Weckesser M, Herzog H, et al. Optimal scan time for fluorine-18 fluurodeoxyglucose positron emission tomography in breast cancer. Eur J Nucl Med 1999; 26: 226-230.
19. 18F-FDG PET Imaging for Differentiating Malignant from Inflammatory Processes. J Nucl Med 2001; 42: 1412-1417.
20. 18F-FDG PET of Breast Cancer: Characterization and Method to Adjust fbr Time Differences. J Nucl Med 2003; 44: 1044-1050.
21. Cohade C, Osman M, Pannu HK, Wahl RL. Uptake in supraclavicular area fat ("USA-Fat"): description oil 18F-FDG PET/CT. J Nucl Med 2003; 44: 170-176.
22. Yeung, HW, Grewal RK, Gonen. M, Schoder H, Larson SM. Patterns of [18]F FDG uptake in adipose tissue and muscle: a potential source of false-positives for PET. J Nucl Med 2003; 44: 1789-1796.
23. Huston SF, Botkin C, Yost P, Osman MM. Warm Blanket: A simple common sense solution to the problem of FDG uptake in brown adipose tissue. J Nucl Med 2006; 47: 537P.
24. Nehmeh SA, Erdi YE, Pan T, et al. Four-dimensional (4D) PET/CT imaging of the thorax. Med Phys 2004; 31(12): 3179-86.
25. Boucher L, Rodrigue S, Lecomte R, Benard F. Respiratory gating for 3-dimensional PET of the thorax: Feasibility and initial results," J Nucl Med 2004; 45: 214-219.
26. Pevsner A, Nehmeh SA, Humm JL, Mageras GS, Erdi YE. Effect of motion on tracer activity determination in CT attenuation corrected PE images: a lung phantom study. Med Phys 2005; 32(7): 2358-62.
27. DiFilippo FP, Brunken RC. Do implanted pacemaker leads and ICD leads cause metal-related artifact in cardiac PET/CT? J Nucl Med 2005; 46(3): 436-43.
28. Goerres GW, Hany TF, Kamel E, von, Schulthess GK, Buck A. Head and neck imaging with PET and PET/CT: artefacts from dental metallic implants. Eur J Nucl Med Mol Imaging 2002; 29(3): 367-70
29. Kamel EM, Burger C, Buck A, von Schulthess GK, Goerres GW, Impact of metallic dental implants on CT-based attenuation correction in a combined PET/CT scanner. Eur Radiol 2003; 13(4): 724-8.
30. Goerres GW, Ziegler SI, Burger C, Berthold T, von Schulthness GK, Buck A. Artifacts at PET and PET/CT caused by metallic hip prosthetic material. Radiology 2003: 226: 577-584.
31. Zhao S, Robeltson DD, Wang G, Whiting B, Bae KT. X-ray CT metal artifact reduction using wavelets: an application for imaging total hipprostheses. IEEE Trans Med Imaging 2000; 19(12): 1238-1247.
32. Mirzaei S, Guerchaft M, Bonnier C, Knoll P, Doat M, Braeutigam P. Use of segmented CT transmission map to avoid metal artifacts in PET images by a PET: CT device. BMC.Nucl Med 2005; 14: 5(1):3.
33. Yazdi M, Gingras L, Beaulieu L. An adaptive approach to metal artifact reduction in helical computed tomography for radiation therapy treatment planning: experimental and clinical studies. Int J Radiat Oncol Biol Phys 2005. Jul 15; 62(4): 1224-31
34. Coolens C, Childs PJ. Calibration of CT Hounsfield units for radiotherapy treatment planning of patients with metallic hip prostheses: the use of the extended CT-scale. Phys Med Biol 2003; 7:48(11): 1591-603.
35. Mahnken AH, Raupach R, Wildberger JE, et al. A new algorithm for metal artifact reduction in computed tomography: in vitro and in vivo evaluation after total hip replacement.. Invest Radiol 2003; 38(12): 769-75.
36. Osman MM, Cohade C, Nakamoto Y, Wahl RL. Respiratory motion artifacts on PET emission images obtained using CT attenuation correction on PET-CT. Eur J Nucl Med Mot Imaging 2003; 30(4): 603-6.
37. Goerres GW, Kamel E, Heidelberg TN, Schwitter MR, Burger C, von Schulthess GK. PET-CT image co-registration in the thorax: influence of respiration. Eur J Nucl Med Mol Imaging 2002; 29(3): 351-60.
38. Beyer T, Antoch G, Blodgett T, Freudenberg LF, Akhurst T, Mueller S. Dual-modality PET/CT imaging: the effect of respiratory motion on combined image quality in clinical oncology. Eur J Nucl Med Mol Imaging 2003; 30(4): 588-96.
39. Pureshbabu W, Mawlawi O. PET/CT imaging artifacts. J Nucl Med Technol 2005; 33(3):156-61.
40. Cohade C, Osman M, Marshall LN, Wahl RN. PET-CT: accuracy of PET and CT spatial registration of lung lesions. Eur J Nucl Med Mol Imaging 2003; 30(5): 721-6.
41. Erdi YE, Nehmeh SA, Pan T, et al. The CT motion quantitation of lung lesions and its impact on PET-measured SUVs. J Nucl Med 2004; 45(8): 1287-92.
42. Pan T, Mawlawi O, Nehmeh SA, et al. Attenuation correction of PET images with respiration-averaged CT images in PET/CT. J Nucl Med 2005; 46(9): 1481-7.
43. Brunken RC, Difilippo FP, Howe WC, Baker MT, White RD, Stillman AE. Measurement of left ventricular ejection fraction using gated cardiac PET with CT based attenuation correction. JNM 2005 Sup (2); 46((5): 173P.
44. Dieckmann W, Maass-Moreno R, Le Meunier L, Bacharach SL. Is CT based cardiac attenuation correction affected by cardiac contraction? JNM 2005 Sup (2); 46((5): 106P.
45. Thomdyke B, Schreibmann E, Koong A, Xing L. Reducing respiratory motion artifacts in positron emission tomography through retrospective stacking. Med Phys 2006; 33(7): 2632-41.
46. Qiao F, Pan T, Clark JW Jr, Mawlawi OR. A motion-incorporated reconstruction method for gated PET studies. Phys Med Biol 2006; 7: 51(15): 3769-83.
47. Antoch G, Freudenberg LS, Egelhof T, et al. Focal tracer uptake: a potential artifact in contrast-enhanced dual-modality PET/CT scans. J Nucl Med 2002; 43: 1339-1342.
48. Cohade C, Osman M, Nakamoto Y, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med 2003; 44; 412-416.
49. Dizendorf E, Hany TF, Buck A, von Schulthess GK, Burger C. Cause and magnitude of the error induced by oral CT contrast in CT-based attenuation correction of PET emission studies. J Nucl Med 2003; 44: 732-738.
50. Nakamoto Y, Chin BB, Kraitchman DL, Lawler LP, Marshall LT, Wahl RL. Effects of nonionic intravenous contrast agents at PET/CT imaging: phantom and canine studies. Radiology 2003; 227(3): 817-24.
51. Mawlawi O, Erasmus JJ, Munden RF, et al. Quantifying the effect of IV contrast media on integrated PET/CT: clinical evaluation. AJR Am J Roentgenol 2006; 186(2): 308-19.
52. Berthelsen AK, Holm S, Loft A, Klausen TL, Andersen F, Higaard L. PET/CT with intravenous contrast can be used for PET attenuation correction in cancer patients. Eur J Nucl Med Mol Imaging 2005; 32(10): 1167-75.
53. Nehmeh SA, Erdi YE, Kalaigian H, et al. Correction for oral contrast artifacts in CT attenuation-corrected PET images obtained by combined PET/CT. J Nucl Med 2003; 44(12): 1940-4.
54. Carney J, Beyer T, Brasse D, Yap JT, Townsend DW. CT based attenuation correction for PET-CT scanner in the presence of contrast agent. Nuclear Science Symposium Conference record. IEEE 2002; 3: 1443-1446.
55. Lonn, A.H.R.; Evaluation of method to minimmize the effect of X-ray contrast in PET-CT attenuation correction Nuclear Science Symposium Conference Record. IEEE 2003; 3: 2220-2221.
56. Antoch G, Kuehl H, Kanja J, et al. Dual modality PET/CT scanning with negative oral contrast agent to avoid artifacts: introduction and evaluation. Radiology 2004; 230(3): 879-85.
57. Hasegawa BH, Lang TF, Brown, EL. Object specific attenuation correction of SPECT with correlated dual-energy X-Ray CT. IEEE Trans Nucl Sci 1993 NS-40: 1242-1252.
58. Bacharach SL, Freedman NMT, Maass-Moreno R, Le Meunier L. Dual energy CT for derecting contrast media in PET/CT. JNM 2005 Sup (2); 46((5):168P.
59. Kinahan PE, Alesio AM, Fesslep JA, Lewellen TK, Vesselle HJ. A simple dual energy method for CT-based attenuation correction that accounts for contrast agents in PET/CT imaging. JNM 2005 Sup (2); 46(5): 113P.
60. Carney J, Beyer T, Yap JT, Townsend DW. CT-Based Attenuation Correction for PET/CT Scanners. In: Schulthess GKV, ed. Clinical molecular anatomic imaging: PET, PET/CT, and SPECT/CT, Philadelphia: Lippincott Williams & Wilkins 2003; 51-58.
61. Mawlawi O, Erasmus JJ, Pan T, Cody D, Campbell R, Lonn A, Kohlmyer S, Macapinlac HA, Podoloff PA. Truncation artifact in PET/CT imaging: Impact on measurements of activity concentration and assessment of a correction algorithm. AJR 2006 (In Press).
62. Carney J, Townsend DW. CT-based attenuation correction: the effects of imaging with the arms in the field of view. JNM 2001; 42: 56P-57P.
63. Lonn AH, Hsieh J, Stearns c, Chao EH, Grekowicz B. Evaluation of extension of the CT attenuation map in PET-CT. JNM 2003; 44: P123.
64. Hsieh J, E. Chao, J. Thibault, et al. A novel reconstruction algorithm to extend the CT scan field of view. Med Phys 2004; 31: 2385-2391.
65. Ohnesorge B, Flohr T, Schwarz K, Heiken JP, Bae KT. Efficient correction for CT image artifacts caused by objects extending outside the scan field of view. Med Phys 2000;27: 39-46.